MSI2 and neoplasm: Furthermore, while there was no difference in the frequency of low-grade tumors, there was a significant decrease in the frequency of mid- and high-grade tumors (45–54%), suggesting that loss of Msi2 delayed tumor progression from low to high grade (Figure 3E).